Image via Wikipedia
Plerixafor has allowed doctors to collect stem cells from patients where there had been previous difficulties.
The drug, which has only recently been licensed, is being used at the Beatson West of Scotland Cancer Centre.
Stem cells therapies are used to treat people with cancer of the blood. The cells are collected and reintroduced to a patient after chemotherapy.
Doctors often encounter problems collecting enough stem cells from about one in 10 cancer patients to undergo treatment.
Plerixafor has, so far, had a 100% success rate in allowing doctors at the cancer centre to collect enough cells from patients who fall
Image by Menage a Moi via Flickr
Destroying abnormal stem cells could be a way to kill off bowel cancer in its very earliest stages, say UK experts.
Immature cells line the gut and normally replace and repair the tissue but malfunctions can lead to cancer.
Scientists believe detecting and obliterating these rogue cancer stem cells as soon as they appear could be a potent new anti-cancer strategy.
A UK National Stem Cell Network conference heard the same method might also work for other cancers.
Professor Malcolm Alison, of Barts and The London School of Medicine, has been looking at how bowel cancers grow
The British Association of Aesthetic Plastic Surgeons (BAAPS) has warned against “stem-cell” breast augmentation at the group’s annual conference in Birmingham.
Senior plastic surgeons of association said, stem-cell breast augmentations are unproven and should not be offered commercially.
“To think that this unproven research is hijacked and used in the commercial sector is really an appalling thought,” former BAAPS president and consultant plastic surgeon Adam Searle told the BBC. “Not least when it’s being utilized by inadequately trained practitioners.”
“Stem Cell” breast augmentation is a variation of traditional breast augmentation using fat grafting, which involves harvesting fat from areas where it is